Featured
Last news
BlackBerry to Participate in Upcoming Investor Events
BlackBerry Executives to speak at upcoming Baird and Wells Fargo conferences
Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer
With more than $10m in cash, and a significantly reduced burn rate, the Company is positioned to fully fund the development of its technology platform.
Paragon Board Responds to Gad's Latest Misleading Statements - Shareholders Deserve the Truth
Gad Continues Pattern of Lying to Shareholders and Misrepresenting the Facts
Tonner One World Eliminates Over $700,000 in Toxic Debt, Signs Agreement to Acquire $1.3M Revenue-Generating Company, and Outlines Strategy for Growth and Market Advancement
With major debt eliminated, revenue-accretive acquisitions underway, and new AI tools in development, Tonner signals a transformative leap in its operational and shareholder value strategy.
Coder Wins 2025 AI TechAward for Best Innovation in AI Integration: Business-to-Business
AI software development company recognized for excellence in developer technology
Pascal Hinnen Joins Kleinfelder as Executive Vice President and Central Division Director
SAN DIEGO, CA / ACCESS Newswire / May 20, 2025 / The Kleinfelder Group, Inc. ("Kleinfelder"), a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm, announced today that Pascal Hinnen, PE, has joined the firm as Executive Vice President and Central Division Director. Hinnen will oversee operations throughout Kleinfelder's Central Division, providing leadership focused on sustained growth and operational excellence.
1606 Corp. Announces Transition to OTCID Tier, Marking a Major Step for the Company
PHOENIX, ARIZONA / ACCESS Newswire / May 20, 2025 / 1606 Corp. (OTC:CBDW) (the "Company") is pleased to announce that, effective July 1, 2025, the Company will be moving from the OTC Pink to the OTC ID designation within the OTC Markets platform. This upgrade represents a meaningful advancement in the Company's transparency, regulatory compliance, and overall market visibility as it continues to position itself for long-term growth.
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
LAS VEGAS, NV / ACCESS Newswire / May 20, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are in talks with an international healthcare innovation company to license or potentially acquire its patented early disease detection technology. If successful, it's a global license or acquisition that has the potential to revolutionize preventive health reporting and to generate correlations for future detection of new diseases without the need for all the patient's data.
Arrive AI Inks Deal with Go2 Delivery Setting the Stage for Secure Medication Delivery in Virginia
Arrive AI technology poised to bring autonomous delivery to Hampton Roads, Richmond and Norfolk ahead of other locations
CXApp Inc. (Nasdaq: CXAI) Reports Strong Q1'25 Customer Success Metrics and Adoption of Agentic AI based CXAI Platform
Highest Subscription Revenue Ratio (99%) and Gross Margin (88%) with 3 large customer expansion renewals at 130%+CXAI Kiosk and CXAI VU being utilized for RTO (Return-to-Office) initiatives across large enterprises
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, is pleased to invite investors to a webinar on May 22, 2025, at 4:15 p.m. ET.
Amaze Named Exclusive Merchandise Partner for Ghost Gaming as Creator Economy Expands
Fans Can Shop Official Merchandise from Ghost Gaming, with Exclusive Designs Launching at DreamHack Dallas May 23-25
Cytta Corp. Formally Launches Cytta Labs, Repositions as IP-Holding Platform Backed by TrueWealth(TM) Vision and Strategic Studio Model
Cytta Labs Begins Aggressive Public Spinout Program with Two New Special Purpose Vehicles
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
New ISOLED-D™ line delivers premium, scalable deuterated reagents for OLED synthesis, supporting the industry from R&D through commercial production with CIL's global manufacturing and expertise.
Polar bear biopsies to shed light on Arctic pollutants
With one foot braced on the helicopter's landing skid, a veterinarian lifted his air rifle, took aim and fired a tranquiliser dart at a polar bear.
5 Top Rated Gold IRA Companies in 2025 (Best Gold IRA Companies List Released)
IRAEmpire.com has released an updated list of the best gold IRA companies of 2025.
Applied Energetics Announces Appointment of Kevin Gunde, PhD, as Senior Vice President, Head of Engineering
TUCSON, AZ / ACCESS Newswire / May 19, 2025 / Applied Energetics, Inc. (OTCQB:AERG), a company engaged in the development of advanced optical technologies and pulsed laser systems, today announced the appointment of Kevin Gunde, PhD, a veteran executive and scientist with over 30 years of leadership experience in the defense sector and intelligence domain, as its Head of Engineering, effective immediately. Dr. Gunde joined the Company's Advisory Board in September of 2022 and since then transitioned to Senior Advisor. Throughout his career, Dr. Gunde has led teams which specialize in development, deployment, productization and the transfer of innovative technologies from research laboratories to the operational elements of the defense and intelligence communities.
The Critical Need for Governance, Risk, and Compliance in Healthcare AI
TAMPA, FL / ACCESS Newswire / May 19, 2025 / As artificial intelligence (AI) transforms healthcare, organizations face unprecedented opportunities-and risks. From clinical decision support to patient engagement, AI-enabled technologies promise efficiency and innovation. However, without robust governance, risk management, and compliance (GRC) frameworks, these advancements can lead to ethical dilemmas, regulatory violations, and patient harm. Newton3, a Tampa-based strategic advisory firm, specializes in helping healthcare leaders navigate this complex landscape, ensuring AI deployments are both impactful and accountable.
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
BRIDGEWATER, NJ / ACCESS Newswire / May 19, 2025 / Tharimmune, Inc. (Nasdaq:THAR), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced the appointment of James Gordon Liddy (CDR US Navy SEAL (Ret)) as a strategic advisor. Mr. Liddy, an internationally recognized expert on counterterrorism and critical infrastructure protection, will provide invaluable guidance as Tharimmune advances the development of TH104, its lead program for temporary prophylaxis against respiratory and/or central nervous system depression in military personnel and chemical incident responders exposed to high-potency opioids, including potential weaponized agents like fentanyl.
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
IRVINE, CA / ACCESS Newswire / May 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, announced the appointment of Jennifer Bright as Chief Financial Officer, effective today, May 19, 2025. Ms. Bright brings more than 25 years of financial and strategic leadership experience built across several commercial-stage medical device and pharmaceutical companies including Biolase, Spectrum Pharmaceuticals, Apria Healthcare, Smile Brands, and Teleflex Medical, as well as technical accounting and auditing experience at PricewaterhouseCoopers LLP.
Arrive AI and Hancock Health Launch Robotic Medical Deliveries at Hancock Regional Hospital
Groundbreaking Automation Poised to Deliver Enhanced Efficiency and Patient CareMarks Arrive AI's First Revenue Generating Arrive PointTM Deployment
BroadSat and WidePoint Build a Dome of Defense with Secure EdgeAI for Smart Cities and Federal Networks
Partnership combines cybersecurity, EdgeAI, and broadcast broadband to create a Dome of Defense for mission-critical applications and connected environments across smart cities, defense, and federal networks.
Affluence Corporation Completes Acquisition of Mingothings SLU
Strategic acquisition to expand market reach and ensure profitable growth.
CAVU Resources, Inc. Reports 1st Quarter Results and Has a One Time Net Gain of $1,236,216
TULSA, OK / ACCESS Newswire / May 19, 2025 / CAVU Resources, Inc. (OTC PINK:CAVR) CAVU releases its First Quarter 2025 earnings report and is pleased to announce that the first quarter reflects a one-time net gain of $1,236,216, compared to a gain of $125,169 for the same period in 2024. For the three-month period, revenue increased by $1,111,047, representing a 887% increase year over year.
Aspira Announces First Quarter 2025 Financial Results and Provides Business Update
AUSTIN, TX / ACCESS Newswire / May 19, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three-month period ended March 31, 2025. The Company also reported early progress under its new leadership team. Key financial highlights for the quarter are summarized below:
Visium Technologies Secures Landmark $20 Million Contract for National Data Centers in West Africa
Contract Announced at AmCham Business Summit
Swarmer and SpiderOak Partner to Secure Autonomous Drone Operations in Contested Environments
Strategic collaboration delivers zero-trust security and resiliency for military autonomous swarm operations, including those deployed in electronic warfare zones
Global chip giants converge on Taiwan for Computex
Global semiconductor chip giants will gather at Taiwan's top tech expo this week to showcase "the next frontier" for an industry dominated by artificial intelligence.
Eurovision favourite KAJ shines spotlight on Finland's Swedish- speaking minority
Comedy act KAJ, the favourite to win Saturday's Eurovision Song Contest for Sweden, has shone a spotlight on Finland's small Swedish-speaking minority, little-known outside the Nordic region, Finnish officials say.
BitMine Immersion Technologies, Inc. Announces Reverse Stock Split
LAS VEGAS, NV / ACCESS Newswire / May 16, 2025 / BitMine Immersion Technologies, Inc. ("BitMine" or the "Company") (OTCQX:BMNR) is pleased to announce a 1 for 20 reverse split of its common stock. The reverse split will be effective Friday May 16, 2025 at 9:00 a.m. eastern time. No fractional shares shall be issued in connection with the reverse split, and any shareholders who otherwise would be entitled to receive fractional shares of common stock shall be entitled to receive cash equal to the market value of its fractional share at the closing price of the common stock on May 15, 2025.
Eva Live Inc. Reports Record First Quarter Results for 2025: Revenue Up 65%, Net Income Surpasses $1.9 Million
LOS ANGELES, CA / ACCESS Newswire / May 16, 2025 / Eva Live Inc. (OTCQB:GOAI), a leading AI-driven advertising technology company, today announced its unaudited financial results for the first quarter ended March 31, 2025, delivering record-breaking growth in both revenue and profitability.
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation in its strategic direction. This change underscores the company's commitment to leveraging advanced artificial intelligence technologies to revolutionize customer acquisition and engagement across healthcare, biotech, and other sectors.